Royalty Pharma’s IPO Raises Nearly $2.2 Billion
It invests in biotech and pharmaceutical companies in exchange for a royalty stream…
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
It invests in biotech and pharmaceutical companies in exchange for a royalty stream…
Hedge fund managers, corporate CEOs, and large, individual traders are all spreading their own “fake news.” How can we...
The best model could only detect deepfakes with 65% accuracy. That’s nowhere near good enough for social media sites...
Whether the headlines are accurate or not, uncertainty around the virus can move markets…
After scrambling for the last four months in search of a COVID-19 treatment, it turns out we had one...
Verve’s CRISPR therapy seeks to introduce a helpful genetic mutation to people at risk of heart disease…
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.